|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.
The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by JMP Securities on October 13, 2021. The analyst firm set a price target for 60.00 expecting PTGX to rise to within 12 months (a possible 85.07% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $32.42 last updated Tue Oct 26 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Protagonist Therapeutics.
Protagonist Therapeutics’s $Q3 earnings are confirmed for after-market on $November 8, 2021.
There is no upcoming split for Protagonist Therapeutics.
Protagonist Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.